Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc.

Overview
Date Founded

1987

Headquarters

9360 Towne Centre Drive,San Diego, CA 92121

Type of Company

Private

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.

Website

http://www.amylin.com

Contact Data
Trying to get in touch with decision makers at Amylin Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Christine Zedelmayer

Head-Investor Relations

Mark Mahmood

Senior Director of Marketing, Byetta & Bydureon

Toya Mcwilliams

Senior Director

Board of Directors
P. Joseph Campisi

Director & Vice President at Celgene Corp.

Jeffrey Galik

Treasurer & Director at Medarex, Inc.

Demetrios Kydonieus

Director & Vice President at Amylin Pharmaceuticals, Inc.

Trending People
Manchester United Limited
Bruno Fernandes hails 'almost perfect' Manchester United performance - The Independent UK
Instagram LLC
Explainer More than you need to know about Harry and Meghan’s Oprah interview, a... - The Salt Lake Tribune
National Basketball Association, Inc.
NBA cracks down on Atlanta promoters planning All-Star Game events - CNN
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
Trending Organizations
Manchester United Limited
Bruno Fernandes hails 'almost perfect' Manchester United performance - The Independent UK
Instagram LLC
Explainer More than you need to know about Harry and Meghan’s Oprah interview, a... - The Salt Lake Tribune
National Basketball Association, Inc.
NBA cracks down on Atlanta promoters planning All-Star Game events - CNN
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
Paths to Amylin Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Amylin Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

AstraZeneca Plc purchases Amylin Pharmaceuticals, Inc. /Diabetes Drug Ops from Amylin Pharmaceuticals, Inc.

Details Hidden

Bristol-Myers Squibb Company purchases Amylin Pharmaceuticals, Inc.

Details Hidden

Amylin Pharmaceuticals, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor
Goldman Sachs & Co. LLC

Advised onBristol-Myers Squibb Company purchases Amylin Pharmaceuticals, Inc.

Underwriter
Lehman Brothers, Inc.

Advised onAmylin Pharmaceuticals, Inc. issued USD Common Stock

Underwriter
Morgan Stanley & Co. LLC

Advised onAmylin Pharmaceuticals, Inc. issued USD Common Stock

Head, Biotechnology Investment Banking
Charles W. Newton

Advised onBristol-Myers Squibb Company purchases Amylin Pharmaceuticals, Inc.

Legal Advisor
Ann Beth Stebbins

Advised onBristol-Myers Squibb Company purchases Amylin Pharmaceuticals, Inc.

Investment Advisor
Chuck F. Adams

Advised onBristol-Myers Squibb Company purchases Amylin Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor
Charles S. Kim

Partner, San Diego at Cooley LLP

Legal Advisor
Nancy Lieberman

Of Counsel at Skadden, Arps, Slate, Meagher & Flom LLP

Legal Advisor
Sean Clayton

Partner, San Diego at Cooley LLP
Non-Profit Donations & Grants
$50K - $100K
2014
Pennington Biomedical Research Foundation

$50K - $100K
2013
Pennington Biomedical Research Foundation

$1,000 - $2,499
2013
Joslin Diabetes Center, Inc.

Non-Profit Donations & Grants Received
$598K
2012
JDRF International

Political Donations
$5,000
2012
John Boehner

$1,000
2012
Robert Brian Gibbs

$1,000
2012
William Leslie Johnson

Investments
Details Hidden
Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Details Hidden
Altea Therapeutics Corp.

Altea Therapeutics Corp. develops pharmaceutical products. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The firm also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. The company was founded by Jonathan A Eppstein and Deborah Eppstein in 1998 and is headquartered in Atlanta, GA.

Details Hidden
Xenome Ltd.

Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia.

Investors
Details Hidden
Sequoia Capital

Sequoia Capital seeks investment opportunities in companies located in the US. The firm target companies operating in the fields of consumer and enterprise. It provides financing for early and growth transactions.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amylin Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amylin Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amylin Pharmaceuticals, Inc..